Latest Regulatory News

CuFe Ltd has expanded its Orlando Deposit resource at Tennant Creek by incorporating significant bismuth and silver, enhancing the project's economic potential and positioning it among Australia's largest bismuth resources.

Macquarie Asset Management has tabled a $5.20 per share cash offer to acquire Qube Holdings, valuing the logistics giant at approximately $11.6 billion. The Qube board has entered an exclusivity agreement and signals unanimous support, pending due diligence and regulatory approvals.

Island Pharmaceuticals has secured membership in the Medical Countermeasures Coalition, positioning its antiviral Galidesivir for critical US government stockpiling and regulatory milestones.

BHP Group has officially ended talks to combine with Anglo American, choosing instead to focus on its own growth strategy. The mining giant acknowledges the strategic benefits of a merger but remains confident in its independent path forward.

Osmond Resources has released confirmatory assay results from its Orión EU Critical Minerals Project in Spain, revealing high-grade titanium, zirconium, hafnium, and rare earth element mineralisation. These findings reinforce the project's potential as a globally significant source of critical minerals.

Southern Palladium fast-tracks development at its Bengwenyama PGM Project, advancing drilling and infrastructure plans while securing key regulatory approvals.

Estrella Resources reports strong progress at its Werumata Limestone Project with over 70% of drilling completed, alongside promising manganese intersections at Ira Manganese Prospect. Infrastructure and feasibility studies are underway, positioning the company as a first mover in Timor-Leste’s emerging mining sector.

Echo IQ has completed a pivotal clinical validation of its EchoSolv HF software at the Mayo Clinic, achieving outstanding accuracy ahead of its FDA submission. This milestone sets the stage for potential US market entry into a $60 billion heart failure diagnostics sector.

Somerset Minerals confirms robust high-grade copper mineralisation at its Jura North prospect within the Coppermine Project, Nunavut, with plans for an aggressive 2026 drilling campaign and regional exploration across its extensive landholding.

PYC Therapeutics has secured Safety Review Committee approval to escalate dosing in its clinical trial for PYC-003, an RNA therapy targeting Polycystic Kidney Disease. This milestone moves the drug closer to pivotal Phase 2/3 trials.

Aura Energy has secured a new exploration permit in Sweden, adjacent to its existing Häggån project, positioning the company to deepen its stake in a globally significant polymetallic resource area.

The a2 Milk Company has secured key regulatory approvals in China, moving closer to launching its infant formula products under the a2MC brand by mid-2027.